期刊文献+

格列本脲对野百合碱诱导的大鼠肺动脉高压的影响及其可能机制 被引量:5

The effect and mechanism of glyburide on monocrotaline-induced pulmonary hypertension in rats
下载PDF
导出
摘要 目的初步探讨格列本脲对野百合碱诱导的大鼠肺动脉高压的作用及其可能机制。方法将8周雄性Sprague-Dawley(SD)大鼠采用数字表法随机分为3组:对照组、野百合碱组、野百合碱+格列本脲组。采用经颈静脉右心导管插管术检测大鼠右心室收缩压,计算右心室肥厚指数,HE染色观察肺血管重构,ELISA、Western blotting法检测Nucleotide-binding domain and leucine-rich repeat PYD-containing protein 3(NLRP3)表达水平及白介素-1β(interleukin-1β,IL-1β)质量浓度。结果用药4周后,与对照组相比,野百合碱组大鼠右心室收缩压明显升高1.66倍(P<0.001),右心室肥厚指数显著增加2.15倍(P<0.001),肺血管中膜厚度增加1.20倍(P<0.001),肺组织NLRP3的表达升高1.57倍(P<0.05),血浆中IL-1β质量浓度明显升高[(1 915.82±316.47)pg/m L vs(118.29±27.60)pg/m L,P<0.001]。与野百合碱组相比,野百合碱+格列本脲组用药4周后右心室收缩压明显下降(33.60±5.14)%(P<0.05),右心室肥厚指数降低(18.26±9.23)%(P<0.05),肺血管中膜厚度减少(21.86±8.64)%(P<0.001),肺组织NLRP3的表达降低(55.96±19.33)%(P<0.01),血中IL-1β质量浓度明显降低[(396.64±237.19)pg/m L vs(1 915.82±316.47)pg/m L,P<0.001]。结论格列本脲可缓解野百合碱诱导的大鼠肺动脉高压,其机制可能与抑制NLRP3/IL-1β的表达有关。 Objective To investigate whether glyburide could prevent monocrotaline( MCT)-induced pulmonary hypertension( PH)via inhibiting nucleotide-binding domain and leucine-rich repeat PYD-containing protein 3( NLRP3) inflammasome activation in rats.Methods Male Sprague-Dawley( SD) rats were divided into 3 groups: control group,MCT group and MCT + glyburide group.Hemodynamic changes, right ventricular hypertrophy, and lung morphological features were assessed. The levels of NLRP3 and interleukin-1β( IL-1β) were assessed by Western blotting and ELISA. Results Compared with control group,four weeks after MCT injection,the right ventricular systolic pressure( RVSP),the index of right ventricular hypertrophy( RVHI) and the percentage of medial thickness( MT%) of pulmonary artery significantly increased by 1. 66( P〈0. 001),2. 15( P〈0. 001) and 1. 20 folds( P〈0. 001),respectively. Compared with MCT group,they reduced by( 33. 60 ± 5. 14) %( P〈0. 05),( 18. 26 ± 9. 23) %( P〈0. 05) and( 21. 86± 8. 64) %( P〈0. 001) in MCT + glyburide group. Compared with control group,the expression of NLRP3 in lung of MCT group increased by 1. 57 folds( P〈0. 05),while it decreased by( 55. 96 ± 19. 33) %( P〈0. 01) after using glyburide in 4 weeks. The serum level of IL-1β was higher in MCT group than that in control group [( 1 915. 82 ± 316. 47) pg / m L vs( 118. 29 ± 27. 60) pg / m L,P〈0. 001],while it was lower in MCT + glyburide group than that in MCT group [( 396. 64 ± 237. 19) pg / m L vs( 1 915. 82 ± 316. 47) pg /m L,P〈0. 001]. Conclusion These results suggested that glyburide could ameliorate MCT-induced pulmonary hypertension that was mediated by the NLRP3 / IL-1β pathway.
出处 《首都医科大学学报》 CAS 北大核心 2015年第5期723-728,共6页 Journal of Capital Medical University
基金 国家自然科学基金(81370152 81300044 31200865) 北京市自然科学基金(7142027)~~
关键词 格列本脲 NLRP3 野百合碱 肺动脉高压 glyburide NLRP3 monocrotaline pulmonary hypertension
  • 相关文献

参考文献20

  • 1Nef H M,Mollmann H,Hamm C,et al.Pulmonary hypertension:updated classification and management of pulmonary hypertension[J].Heart,2010,96(7):552-559.
  • 2Fernańdez R A,Sundivakkam P,Smith K A,et al.Pathogenic role of store-operated and receptor-operated Ca2+channels in pulmonary arterial hypertension[J].J Signal Transduct,2012,2012:951497.
  • 3Meloche J,Renard S,Provencher S,et al.Anti-inflammatory and immunosuppressive agents in PAH[J].Handb Exp Pharmacol,2013,218:437-476.
  • 4Yoon J,Ryoo S.Arginase inhibition reduces interleukin-1β-stimulated vascular smooth muscle cell proliferation by increasing nitric oxide synthase-dependent nitric oxide production[J].Biochem Biophys Res Commun,2013,435(3):428-433.
  • 5Lamkanfi M,Kanneganti T D.Nlrp3:an immune sensor of cellular stress and infection[J].Int J Biochem Cell Biol,2010,42(6):792-795.
  • 6Schroder K,Tschopp J.The Inflammasomes[J].Cell,2010,140(6):821-832.
  • 7Lamkanfi M,Mueller J L,Vitari A C,et al.Glyburide inhibits the Cryopyrin/Nalp3 inflammasome[J].J Cell Biol,2009,187(1):61-70.
  • 8Thomas H C,LaméM W,Dunston S K,et al.Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells[J].Toxicol Appl Pharmacol,1998,151(2):236-244.
  • 9刘杰,杜雨轩,王望,国桓,王军,王辰.雷帕霉素对野百合碱诱导的大鼠肺动脉高压及肺血管重构的影响[J].首都医科大学学报,2013,34(4):554-558. 被引量:4
  • 10Montani D,Günther S,Dorfmüller P,et al.Pulmonary arterial hypertension[J].Orphanet J Rare Dis,2013,8:97.

二级参考文献16

  • 1Nef H M, Mollmann H, Hamm C, et al. Pulmonary hyper?tension: updated classification and management of pulmona?ry hypertension[J]. Heart, 2010,96(7) :552-559.
  • 2Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology[J]. Eur Respir Rev, 2010,19(115) :59-{)3.
  • 3Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents[J]. Nat Rev Drug Discov, 2006,5(8) :671-{)88.
  • 4Terada N, LucasJ J, Szepesi A, et al. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G 1 phase of the cycle[J].J Cell Physiol, 1993,154(1):7 -15.
  • 5Brown EJ, Albers M W, Shin T B, et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex[J]. Nature, 1994 ,369( 6483) : 756-758.
  • 6Barst R 1. PDGF signaling in pulmonary arterial hyperten?sion[J].J Clin Invest, 2005,115 (10) :2691- 2694.
  • 7Gessler T, Seeger W, Schmehl T. Inhaled prostanoids in the therapy of pulmonary hypertension[J].J Aerosol Med Pulm Drug Deliv, 2008,21 (1) : 1 -12.
  • 8Mohacsi PJ, Tuller D, Hulliger B, et al. Different inhibi?tory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stim?ulated by platelet-derived growth factor or endothelial cell growth factor[J].J Heart Lung Transplant, 1997, 16 ( 5 ) : 484-492.
  • 9Akselband Y, Harding M W, Nelson P A. Rapamycin in?hibits spontaneous and fibroblast growth factor beta-stimula?ted proliferation of endothelial cells and fibroblasts[J] . Transplant Proc, 1991,23 (6) :2833- 2836.
  • 10Ogawa A, Firth A L, Yao W, et al. Inhibition of mTOR at?tenuates store-operated Ca2+ entry in cells from endarterecto?mized tissues of patients with chronic thromboembolic pul?monary hypertension[J]. AmJ Physiol Lung Cell Mol Physiol, 2009,297(4) :1666-1676.

共引文献3

同被引文献21

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部